Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biodesix Raises FY2025 Sales Guidance from $80.000M-$85.000M to $84.000M-$86.000M vs $83.236M Est

Author: Benzinga Newsdesk | November 03, 2025 04:04pm
Biodesix (NASDAQ:BDSX) raises FY2025 sales outlook from $80.000 million-$85.000 million to $84.000 million-$86.000 million vs $83.236 million estimate.

Posted In: BDSX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist